MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review

MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME82376FSA
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

MDxHealth SA (MDXH)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company's products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prostate cancer; and AssureMDx for bladder cancer. Its pipeline products include InformMDx, SelectMDx (Point of Care) and MonitorMDx which is being developed for Prostate Cancer Test. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in, the Netherlands, Belgium and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

MDxHealth SA Key Recent Developments

Aug 30,2018: MDxHealth announces half year 2018 financial results

Apr 27,2018: MDxHealth releases 2017 Annual Report

Apr 24,2018: MDxHealth Reports First Quarter 2018 Financial Results

Mar 22,2018: MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase

Feb 22,2018: MDxHealth Reports Financial Year 2017 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

MDxHealth SA-Key Facts 6

MDxHealth SA-Key Employees 7

MDxHealth SA-Key Employee Biographies 8

MDxHealth SA-Major Products and Services 9

MDxHealth SA-History 10

MDxHealth SA-Company Statement 15

MDxHealth SA-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Company Overview 18

MDxHealth SA-Business Description 19

R&D Overview 19

MDxHealth SA-Corporate Strategy 20

MDxHealth SA-SWOT Analysis 21

SWOT Analysis-Overview 21

MDxHealth SA-Strengths 21

MDxHealth SA-Weaknesses 22

MDxHealth SA-Opportunities 23

MDxHealth SA-Threats 24

MDxHealth SA-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32

MDxHealth SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 33

MDxHealth SA, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Aug 30, 2018: MDxHealth announces half year 2018 financial results 35

Apr 27, 2018: MDxHealth releases 2017 Annual Report 39

Apr 24, 2018: MDxHealth Reports First Quarter 2018 Financial Results 40

Mar 22, 2018: MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase 42

Feb 22, 2018: MDxHealth Reports Financial Year 2017 Results 43

Nov 02, 2017: MDxHealth Nine Month Trading Update 47

Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion 51

Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results 52

Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion 54

May 08, 2017: MDxHealth Trading Update: January to April 2017 55

Section 6-Appendix 56

Methodology 56

Ratio Definitions 56

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

MDxHealth SA, Performance Chart (2013-2017) 29

MDxHealth SA, Ratio Charts 31

MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32

MDxHealth SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 33

List of Tables

MDxHealth SA, Key Facts 6

MDxHealth SA, Key Employees 7

MDxHealth SA, Key Employee Biographies 8

MDxHealth SA, Major Products and Services 9

MDxHealth SA, History 10

MDxHealth SA, Subsidiaries 17

MDxHealth SA, Key Competitors 25

MDxHealth SA, Ratios based on current share price 26

MDxHealth SA, Annual Ratios 27

MDxHealth SA, Annual Ratios (Cont...1) 28

MDxHealth SA, Interim Ratios 30

MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32

MDxHealth SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 33

MDxHealth SA, Recent Deals Summary 34

Currency Codes 56

Capital Market Ratios 56

Equity Ratios 57

Profitability Ratios 57

Cost Ratios 58

Liquidity Ratios 58

Leverage Ratios 59

Efficiency Ratios 59

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

OPKO Health Inc

Myriad Genetics Inc

Mitomics Inc

Hologic Ltd

Genomic Health Inc

Epigenomics AG

MDxHealth SA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]